Replies to post #106117 on Biotech Values

[ghmm]

I haven't followed them closely but I was surprised to see the PR state the possibility of more trials given the P value. I thought the debate would be around a new REMS? Is it because they want a trial comparing against currently approved drugs? At any rate the stock seems to be holding up quite well.

[rkrw]

Go figure. Jazz is up more than Cypb is up.